Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probiotics: a perspective on problems and pitfalls.

F Shanahan1

  • 1Dept. of Medicine, University College Cork, National University of Ireland. F.Shanahan@ucc.ie

Scandinavian Journal of Gastroenterology. Supplement
|June 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Microbiota is essential for social development in the mouse.

Molecular psychiatry·2026
Same author

Safety of <i>Bifidobacterium breve</i>, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.

Beneficial microbes·2022
Same author

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Same author

Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.

Scientific reports·2022
Same author

Mapping the colorectal tumor microbiota.

Gut microbes·2021
Same author

The gut virome in Irritable Bowel Syndrome differs from that of controls.

Gut microbes·2021
Same journal

Abstract from the 41st Nordic Gastroenterology Congress, 8-11 June 2010, Copenhagen, Denmark.

Scandinavian journal of gastroenterology. Supplement·2010
Same journal

Abstracts from the XL Nordic Meeting of Gastroenterology, June 8-11, 2009, Stavanger, Norway.

Scandinavian journal of gastroenterology. Supplement·2009
Same journal

Abstracts of the 39th Nordic Meeting of Gastroenterology, 30th Nordic Meeting of Digestive Endoscopy, 18th Nordic Meeting of Gastrointestinal Motility, and the Annual Endoscopy/Gastroenterology Nurses'/Assistants' Meeting Post-graduate course, 4-6 June 2008, Helsinki, Finland.

Scandinavian journal of gastroenterology. Supplement·2008
Same journal

Abstracts from the XXXVIII Nordic Meeting of Gastroenterology, XXIX Nordic Meeting of Digestive Endoscopy, XVII Nordic Meeting of Gastrointestinal Motility, 6-9 June 2007, Reykjavik, Iceland.

Scandinavian journal of gastroenterology. Supplement·2007
Same journal

Abstracts of the XXXVII Nordic Meeting of Gastroenterology, 3-5 May 2006, Vasteras, Sweden.

Scandinavian journal of gastroenterology. Supplement·2006
Same journal

Novel approaches in the outpatient care of patients with chronic inflammatory bowel disease.

Scandinavian journal of gastroenterology. Supplement·2006
See all related articles

Probiotics offer potential for various disorders, but knowledge gaps hinder optimal use. Rigorous clinical trials are needed to establish efficacy and guide safe, effective probiotic therapy.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Immunology

Background:

  • Probiotics, or live microorganisms conferring a health benefit, are explored for treating infectious, inflammatory, and neoplastic conditions.
  • Significant knowledge gaps exist regarding normal gut microbiota composition and the optimal application of probiotic interventions.
  • Current in vitro methods lack reliability in predicting the in vivo effectiveness of probiotic strains.

Purpose of the Study:

  • To highlight the current limitations and challenges in probiotic therapy.
  • To emphasize the need for further research to optimize the clinical use of probiotics.

Main Methods:

  • Review of existing literature on probiotic efficacy and clinical application.
  • Identification of key areas requiring further investigation, including strain selection, dosage, and delivery methods.

Related Experiment Videos

  • Emphasis on the necessity of prospective clinical trials for validating probiotic effectiveness.

    • Main Results:

    • No reliable in vitro predictor for in vivo probiotic efficacy currently exists.
    • Probiotic performance must be evaluated relative to specific disease indications.
    • Insufficient data complicates guidelines for routine clinical probiotic use, including strain selection, dosage, and monitoring.

    Conclusions:

    • Resolution of current challenges and pitfalls is essential to realize the therapeutic promise of probiotics.
    • Rigorous, indication-specific clinical trials are paramount for establishing probiotic efficacy and safety.
    • Standardized guidelines for probiotic therapy require further data on optimal usage parameters.